Lenvatinib Capsules IP 4 mg, Lenvakast-4 In Pakistan

Lenvakast-4 Capsules contain lenvatinib 4 mg, an anticancer medicine belonging to a class of drugs known as tyrosine kinase inhibitors (TKIs). It works by blocking certain proteins involved in tumour growth and the formation of blood vessels that supply tumours.

Lenvatinib is used in the treatment of specific cancers under the supervision of an oncologist. Treatment selection depends on the type of cancer, its stage, previous treatments, and the patient's overall health.

Product Information

• Brand Name: Lenvakast-4

• Generic Name: Lenvatinib

• Strength: 4 mg

• Dosage Form: Capsules, as specified in the product description

• Drug Class: Tyrosine kinase inhibitor

• Prescription Status: Prescription-only anticancer medicine

• Country: Pakistan

Medical Uses of Lenvatinib 4mg

Lenvatinib is used for certain types of cancer, including:

• Thyroid cancer: Certain progressive, advanced thyroid cancers that do not respond to radioactive iodine.

• Kidney cancer: Advanced renal cell carcinoma, in combination with other medicines in appropriate treatment settings.

• Liver cancer: Certain cases of unresectable hepatocellular carcinoma.

• Endometrial cancer: Selected advanced cases, in combination with pembrolizumab or another approved combination regimen where applicable.

How Does Lenvatinib Work?

Lenvatinib blocks specific enzymes involved in tumour growth and the development of blood vessels that supply cancer cells. This can help slow the growth and spread of certain tumours.

Dosage and Administration

Lenvakast-4 contains 4 mg of lenvatinib per capsule. The 4 mg strength does not necessarily represent the complete daily dose. The prescribed dose depends on the cancer type, treatment regimen, body weight in some indications, tolerability, and other medical factors.

Take it exactly as directed by your oncologist. Do not change the dose or discontinue treatment without medical advice.

Possible Side Effects

Possible side effects include:

• High blood pressure

• Fatigue and weakness

• Diarrhoea

• Reduced appetite and weight loss

• Nausea and vomiting

• Protein in the urine

• Changes in kidney or liver function

Lenvatinib can also cause serious complications, including bleeding, heart problems, and kidney or liver injury. Regular blood pressure checks and laboratory monitoring are important. Seek urgent medical care for chest pain, severe bleeding, difficulty breathing, or other serious symptoms.

Precautions and Warnings

• Inform your doctor about any kidney, liver, or heart conditions.

• Tell your oncologist about all medicines and supplements you take.

• Pregnancy should be avoided during treatment; discuss contraception with your doctor.

• Breastfeeding is not recommended during treatment.

• Keep the medicine out of reach of children.